{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:01:03Z","timestamp":1791414063642,"version":"4.3.3"},"reference-count":39,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Context<\/jats:title><jats:p>Ulipristal acetate (UPA), a selective progesterone receptor modulator, clinically reduces uterine myoma size in 80% of cases. However, the molecular mechanism of action is still poorly understood, as is the reason why 20% of myomas do not respond to treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To elucidate whether matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are associated with myoma volume shrinkage after UPA therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Prospective study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Academic research unit of a university hospital.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients<\/jats:title><jats:p>Uterine biopsies were obtained from 59 patients with symptomatic myomas undergoing myomectomy, 45 of whom were treated preoperatively with either one or greater than or equal to two, 3-month courses of UPA and 14 not given any hormone therapy to serve as controls. Myoma volume was individually monitored during UPA therapy to determine any substantial clinical response (defined as a reduction in volume of &amp;gt;25%). Three groups were established based on the response to treatment: responsive (R) after one course (n = 12); R after two to four courses (n = 15); and nonresponsive (NR; n = 18).<\/jats:p><\/jats:sec><jats:sec><jats:title>Interventions<\/jats:title><jats:p>UPA treatment given as preoperative management for symptomatic myomas.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcome Measures<\/jats:title><jats:p>MMP and TIMP expression assessed by zymography and immunohistochemistry.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared with controls and NR myomas, responders showed significantly higher expression levels for MMP-1 (P &amp;lt; 0.0001) and MMP-2 (P = 0.009) and significantly lower expression levels for TIMP-1 (P = 0.040).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The correlation found between MMP expression and volume fold change supports the notion that MMPs play a key role in UPA-induced myoma shrinkage.<\/jats:p><\/jats:sec>","DOI":"10.1210\/jc.2017-02295","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T19:07:19Z","timestamp":1517512039000},"page":"1566-1573","source":"Crossref","is-referenced-by-count":28,"title":["Matrix Metalloproteinase Activity Correlates With Uterine Myoma Volume Reduction After Ulipristal Acetate Treatment"],"prefix":"10.1210","volume":"103","author":[{"given":"Guillaume E","family":"Courtoy","sequence":"first","affiliation":[{"name":"P\u00f4le de Recherche en Gyn\u00e9cologie, Institut de Recherche Exp\u00e9rimentale et Clinique, Universit\u00e9 Catholique de Louvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Henriet","sequence":"additional","affiliation":[{"name":"Cell Biology Unit, de Duve Institute, Universit\u00e9 Catholique de Louvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Marbaix","sequence":"additional","affiliation":[{"name":"Cell Biology Unit, de Duve Institute, Universit\u00e9 Catholique de Louvain, Brussels, Belgium"},{"name":"Pathology Department, Cliniques Universitaires St-Luc, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"de Codt","sequence":"additional","affiliation":[{"name":"P\u00f4le de Recherche en Gyn\u00e9cologie, Institut de Recherche Exp\u00e9rimentale et Clinique, Universit\u00e9 Catholique de Louvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Luyckx","sequence":"additional","affiliation":[{"name":"Gynecology and Andrology Department, Cliniques Universitaires St-Luc, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Donnez","sequence":"additional","affiliation":[{"name":"Soci\u00e9t\u00e9 de Recherche pour l\u2019Infertilit\u00e9 (SRI), Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Madeleine","family":"Dolmans","sequence":"additional","affiliation":[{"name":"P\u00f4le de Recherche en Gyn\u00e9cologie, Institut de Recherche Exp\u00e9rimentale et Clinique, Universit\u00e9 Catholique de Louvain, Brussels, Belgium"},{"name":"Gynecology and Andrology Department, Cliniques Universitaires St-Luc, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,2,1]]},"reference":[{"issue":"17","key":"2020071622205216800_B1","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMcp1411029","article-title":"Clinical practice. Uterine fibroids","volume":"372","author":"Stewart","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"2020071622205216800_B2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/humupd\/dmw023","article-title":"Uterine fibroid management: from the present to the future","volume":"22","author":"Donnez","year":"2016","journal-title":"Hum Reprod Update"},{"issue":"3","key":"2020071622205216800_B3","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/gcc.20035","article-title":"Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids","volume":"40","author":"Catherino","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"2020071622205216800_B4","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.fertnstert.2004.04.030","article-title":"Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium","volume":"82","author":"Leppert","year":"2004","journal-title":"Fertil Steril"},{"issue":"1","key":"2020071622205216800_B5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.fertnstert.2013.03.007","article-title":"Complex networks of multiple factors in the pathogenesis of uterine leiomyoma","volume":"100","author":"Islam","year":"2013","journal-title":"Fertil Steril"},{"issue":"2","key":"2020071622205216800_B6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.fertnstert.2015.04.025","article-title":"In vivo mechanisms of uterine myoma volume reduction with ulipristal acetate treatment","volume":"104","author":"Courtoy","year":"2015","journal-title":"Fertil Steril"},{"issue":"4","key":"2020071622205216800_B7","doi-asserted-by":"crossref","first-page":"474.e1","DOI":"10.1016\/j.ajog.2007.11.057","article-title":"Mechanical homeostasis is altered in uterine leiomyoma","volume":"198","author":"Rogers","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2020071622205216800_B8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1055\/s-0035-1558451","article-title":"Uterine leiomyoma stem cells: linking progesterone to growth","volume":"33","author":"Bulun","year":"2015","journal-title":"Semin Reprod Med"},{"issue":"6","key":"2020071622205216800_B9","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2009-1225","article-title":"Progesterone is essential for maintenance and growth of uterine leiomyoma","volume":"151","author":"Ishikawa","year":"2010","journal-title":"Endocrinology"},{"issue":"2","key":"2020071622205216800_B10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.mce.2011.05.044","article-title":"The role of progesterone signaling in the pathogenesis of uterine leiomyoma","volume":"358","author":"Kim","year":"2012","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"2020071622205216800_B11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"2020071622205216800_B12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"2020071622205216800_B13","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.fertnstert.2014.02.008","article-title":"Long-term treatment of uterine fibroids with ulipristal acetate","volume":"101","author":"Donnez","year":"2014","journal-title":"Fertil Steril"},{"issue":"1","key":"2020071622205216800_B14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.fertnstert.2015.09.032","article-title":"Long-term medical management of uterine fibroids with ulipristal acetate","volume":"105","author":"Donnez","year":"2016","journal-title":"Fertil Steril"},{"issue":"6","key":"2020071622205216800_B15","doi-asserted-by":"crossref","first-page":"756.e1","DOI":"10.1016\/j.ajog.2016.02.049","article-title":"Long-term nonsurgical control with ulipristal acetate of\u00a0multiple uterine fibroids, enabling pregnancy","volume":"214","author":"Luyckx","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2020071622205216800_B16","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/GCO.0000000000000229","article-title":"Current management of myomas: the place of medical therapy with the advent of selective progesterone receptor modulators","volume":"27","author":"Donnez","year":"2015","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"3","key":"2020071622205216800_B17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/molehr\/gan004","article-title":"Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells","volume":"14","author":"Xu","year":"2008","journal-title":"Mol Hum Reprod"},{"issue":"3","key":"2020071622205216800_B18","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.fertnstert.2015.07.218","article-title":"Extracellular matrix production decreases in ulipristal acetate (UPA) treated human leiomyomas in vitro and in vivo resulting in decreased fibroid size","volume":"104","author":"Cox","year":"2015","journal-title":"Fertil Steril"},{"issue":"24","key":"2020071622205216800_B19","doi-asserted-by":"crossref","first-page":"11789","DOI":"10.1073\/pnas.89.24.11789","article-title":"Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants","volume":"89","author":"Marbaix","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"17","key":"2020071622205216800_B20","doi-asserted-by":"crossref","first-page":"9120","DOI":"10.1073\/pnas.93.17.9120","article-title":"Menstrual breakdown of human endometrium can be mimicked in vitro and is selectively and reversibly blocked by inhibitors of matrix metalloproteinases","volume":"93","author":"Marbaix","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2020071622205216800_B21","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/his.12867","article-title":"Digital pathology: elementary, rapid and reliable automated image analysis","volume":"68","author":"Bouzin","year":"2016","journal-title":"Histopathology"},{"issue":"1","key":"2020071622205216800_B22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2144\/05381RV01","article-title":"Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors","volume":"38","author":"Snoek-van Beurden","year":"2005","journal-title":"Biotechniques"},{"issue":"9","key":"2020071622205216800_B23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrc884","article-title":"Strategies for MMP inhibition in cancer: innovations for the post-trial era","volume":"2","author":"Overall","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2020071622205216800_B24","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1038\/s41598-017-04648-y","article-title":"Cellular uptake of proMMP-2:TIMP-2 complexes by the endocytic receptor megalin\/LRP-2","volume":"7","author":"Johanns","year":"2017","journal-title":"Sci Rep"},{"issue":"6","key":"2020071622205216800_B25","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/acel.12265","article-title":"Age-associated reduction of cellular spreading\/mechanical force up-regulates matrix metalloproteinase-1 expression and collagen fibril fragmentation via c-Jun\/AP-1 in human dermal fibroblasts","volume":"13","author":"Qin","year":"2014","journal-title":"Aging Cell"},{"key":"2020071622205216800_B26","doi-asserted-by":"crossref","unstructured":"Courtoy GE , DonnezJ, MarbaixE, BarreiraM, LuyckxM, DolmansMM. Progesterone receptor isoforms, nuclear corepressor-1 and steroid receptor coactivator-1 and B-cell lymphoma 2 and Akt and Akt phosphorylation status in uterine myomas after ulipristal acetate treatment: a systematic immunohistochemical evaluation[published online ahead of print December 11, 2017]. Gynecol Obstet Invest. doi: 10.1159\/000480011.","DOI":"10.1159\/000480011"},{"issue":"4","key":"2020071622205216800_B27","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/humrep\/den025","article-title":"Selective progesterone receptor modulator asoprisnil down-regulates collagen synthesis in cultured human uterine leiomyoma cells through up-regulating extracellular matrix metalloproteinase inducer","volume":"23","author":"Morikawa","year":"2008","journal-title":"Hum Reprod"},{"issue":"11","key":"2020071622205216800_B28","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/molehr\/3.11.1005","article-title":"Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotrophin releasing hormone agonist-induced tumour regression","volume":"3","author":"Dou","year":"1997","journal-title":"Mol Hum Reprod"},{"issue":"10","key":"2020071622205216800_B29","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1210\/jc.2005-0762","article-title":"Response of matrix metalloproteinases and tissue inhibitors of metalloproteinases messenger ribonucleic acids to ovarian steroids in human endometrial explants mimics their gene- and phase-specific differential control in vivo","volume":"90","author":"Vassilev","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2020071622205216800_B30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-0030-1251475","article-title":"Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women","volume":"28","author":"Malik","year":"2010","journal-title":"Semin Reprod Med"},{"issue":"5","key":"2020071622205216800_B31","doi-asserted-by":"crossref","first-page":"596.e1","DOI":"10.1016\/j.ajog.2016.05.006","article-title":"Loss of stiffness in collagen-rich uterine fibroids after digestion with purified collagenase Clostridium histolyticum","volume":"215","author":"Jayes","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"2020071622205216800_B32","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1177\/1933719114553449","article-title":"Injectable Clostridium histolyticum collagenase as a potential treatment for uterine fibroids","volume":"21","author":"Brunengraber","year":"2014","journal-title":"Reprod Sci"},{"issue":"1","key":"2020071622205216800_B33","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0304-4165(02)00446-4","article-title":"A comparative analysis of structure and spatial distribution of decorin in human leiomyoma and normal myometrium","volume":"1619","author":"Berto","year":"2003","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"2020071622205216800_B34","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/1933719115607994","article-title":"Proteoglycans in leiomyoma and normal myometrium: abundance, steroid hormone control, and implications for pathophysiology","volume":"23","author":"Barker","year":"2016","journal-title":"Reprod Sci"},{"issue":"3","key":"2020071622205216800_B35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12079-014-0234-x","article-title":"Matrix production and remodeling as therapeutic targets for uterine leiomyoma","volume":"8","author":"Fujisawa","year":"2014","journal-title":"J Cell Commun Signal"},{"issue":"3","key":"2020071622205216800_B36","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.fertnstert.2015.07.008","article-title":"The synchronization of the leiomyoma extracellular matrix signaling pathways of surgical specimens in response to Ulipristal acetate","volume":"104","author":"Malik","year":"2015","journal-title":"Fertil Steril"},{"key":"2020071622205216800_B37","doi-asserted-by":"crossref","first-page":"5316845","DOI":"10.1155\/2017\/5316845","article-title":"Overhydroxylation of lysine of collagen increases uterine fibroids proliferation: roles of lysyl hydroxylases, lysyl oxidases, and matrix metalloproteinases","volume":"2017","author":"Kamel","year":"2017","journal-title":"Biomed Res Int"},{"key":"2020071622205216800_B38","article-title":"Substrate specificity of MMPs","volume-title":"Matrix Metalloproteinase Inhibitors in Cancer Therapy. Vol XIII. 1st ed","author":"Nagase","year":"2001"},{"issue":"1","key":"2020071622205216800_B39","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.cellbio.17.1.463","article-title":"How matrix metalloproteinases regulate cell behavior","volume":"17","author":"Sternlicht","year":"2001","journal-title":"Annu Rev Cell Dev Biol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/4\/1566\/24565688\/jc.2017-02295.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/4\/1566\/24565688\/jc.2017-02295.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T19:37:14Z","timestamp":1660419434000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/103\/4\/1566\/4834038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,1]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2017-02295","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2018,2,1]]}}}